Table 3 |
||||||||
|
The effect of Irvingia gabonensis on blood total cholesterol (TC), triglyceride (TRI), high density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c) and glucose. |
||||||||
| T-cholesterol |
TRI |
HDL-c |
LDL-c |
LDL/HDL |
T-cho/HDL |
GLUCOSE |
||
|
|
||||||||
| Active |
Initial |
215 ± 55.12 |
162 ± 33.15 |
61.23 ± 20.36 |
121.37 ± 36.3 |
1.98 ± 1.78 |
3.51 ± 2.70 |
3.8 ± 1.92 |
| Final |
130.68 ± 39.5 |
89.22 ± 55.63 |
89.9 ± 28.44 |
66.08 ± 34.27 |
0.735 ± 1.20 |
1.45 ± 1.38 |
2.57 ± 1.03 |
|
| Placebo |
Initial |
163.70 ± 25.32 |
130.65 ± 37.82 |
31.38 ± 25.21 |
105.06 ± 11.86 |
5.05 ± 3.94 |
6.44 ± 3.37 |
3.6 ± 0.41 |
| Final |
158.36 ± 30.46 |
100.52 ± 32.55 |
41.20 ± 19.53 |
98.55 ± 27.99 |
3.19 ± 1.85 |
4.51 ± 2.07 |
3.9 ± 0.74 |
|
Ngondi et al. Lipids in Health and Disease 2005 4:12 doi:10.1186/1476-511X-4-12 |
||||||||
